Featured
Last news
Water Tower Research Highlights Mirle Partnership Fueling Ainos' Robotics Scale-Up and SmellTech Expansion
AI Nose integration positions robotics application as a scalable growth engineMirle partnership expands SmellTech robotics into industrial environments
ParkerVision Files Opening Brief for its Expedited Appeal in ParkerVision v. Qualcomm
JACKSONVILLE, FL / ACCESS Newswire / February 5, 2026 / ParkerVision, Inc. ("the Company") (OTCQB:PRKR), a leader in wireless radio-frequency (RF) innovation, announced the filing of its opening brief to the Court of Appeals for the Federal Circuit ("CAFC") in its appeal of the district court decision in ParkerVision v. Qualcomm in the Middle District of Florida. A copy of the Company's opening brief can be found here.
Nextech3D.ai to Report Q3 2025 Earnings After Market Close on February 18, 2026
TORONTO, ON / ACCESS Newswire / February 5, 2026 / Nextech3D.ai (OTCQB:NEXCF)(CSE:NTAR)(FSE:1SS), an AI-first technology company focused on enterprise event technology, immersive engagement, and experiential solutions, today announced that it will release its financial results for the third quarter ended December 31, 2025 after the close of business on Wednesday, February 18, 2026.
Ayrmid Pharma Ltd Announces Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia (SAA) Presented at TANDEM
Omisirge transplantation shows accelerated immune recovery in SAANew data presented at the 2026 TANDEM Meetings demonstrate that patients with SAA who received Omisirge experienced faster and more robust immune recovery compared with patients receiving alternative transplant graft sourcesOmisirge approved by FDA as First Cell Therapy to Treat Severe Aplastic AnemiaKey Highlights of Data Presented at TANDEM:Rapid neutrophil recovery: Median time to neutrophil engraftment was 10 days following Omisirge transplantation. Faster recovery was associated with higher transplanted CD34⁺ cell dosesEnhanced CD4⁺T-cell reconstitution: At six months post-transplant, CD4⁺ T-cell counts were significantly higher in Omisirge recipients compared with other transplant sources including matched and haploidentical donors. Higher CD4⁺ T-cell recovery correlated with more rapid neutrophil engraftmentAccelerated NK-cell recovery: Natural killer (NK) cell reconstitution occurred early after transplant, with median NK-cell counts at days 30 and 100 exceeding those observed across all comparator graft sourcesOmisirge approved by the FDA on December 5, 2025 for SAA
Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 2026
Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue.Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024.The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million.
Ayrmid and Ariti Sign Distribution Agreement for Omisirge(R) in Greece and Cyprus
DUBLIN, IE / ACCESS Newswire / February 5, 2026 / Ayrmid, Ltd. ("Ayrmid" or the "Company"), the parent company of Gamida Cell Inc., today announced that it has entered into an exclusive distribution agreement with Ariti S.A., a Greece based pharmaceutical company for the distribution of Omisirge (Omidubicel-onlv) in Greece and Cyprus.
HEICO Corporation Completes EthosEnergy Accessories and Components Acquisition
Expands HEICO into Aeroderivative Gas Turbine Parts
LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
VANCOUVER, BC / ACCESS Newswire / February 5, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company) is pleased to announce that it has commenced Project Phase 2 peptide design activities with Neuland Laboratories Limited ("Neuland") under the parties' existing services agreement (please see news release dated January 8, 2026).
Lunar Records Announces Formation of Lunar Records Fund #1: The World's First Tokenized Real-World Asset Fund Revolutionizing Music Royalties
BEVERLY HILLS, CA / ACCESS Newswire / February 5, 2026 / Lunar Records today proudly announces the formation of Lunar Records Fund #1, a groundbreaking tokenized real-world asset fund established in January 2026 (the "Fund"). Lunar Records is a joint venture founded by Melody Trust, LLC {a HWAL, Inc. (OTC:HWAL) company} and the SI Blue Foundation ("Space Blue") in 2023 and as part of the Lunarprise Museum Mission, Lunar Records music catalog received notable attention in Billboard Magazine and Rolling Stone when their music, alongside of Lunarbits, the Stan Lee/Legion and Advent project, when they were archived in a time capsule (Lunaprise) that landed on the moon containing 222 art, music, and film archives on 2.22.2024, the first lunar landing for the USA and NASA since 1972.
CyberGuard Advantage Strengthens Executive Leadership Team with Key Appointments to Scale Global Operations
Dylan Anderson (CRO), Neetu Jindal (CHRO), and Jeni Bahr (CFO) join the cybersecurity and compliance leader to drive operational excellence and long-term growth.
CuriosityStream Appoints Industry Veteran John Vilade as Chief Commercial Officer to Accelerate AI Licensing and Partner Growth
SILVER SPRING, MARYLAND / ACCESS Newswire / February 5, 2026 / CuriosityStream Inc. (Nasdaq:CURI), a leading global factual media company, today announced the creation of a new executive leadership position, Chief Commercial Officer, and the appointment of John Vilade to the role, effective immediately. Vilade will report directly to Clint Stinchcomb, CuriosityStream's President and Chief Executive Officer.
Optex Systems Announces First Quarter Earnings Call
RICHARDSON, TX / ACCESS Newswire / February 5, 2026 / Optex Systems Holdings, Inc. (Nasdaq:OPXS), a leading manufacturer of precision optical sighting systems for domestic and worldwide military and commercial applications, announced today that it plans to report its financial performance for the first quarter of fiscal 2026 on Wednesday, February 11th, 2026.
TrackVia to Showcase Modern Operations Management Technology at WEST 2026
Advanced low-code workflow platform helps streamline mission-critical programs, processes and procedures for greater visibility and control anywhere, anytime.
Suggestion Box, Inc. (OTC:SGTB) Announces OTC Markets Current Status and Strategic Pivot to Emerging Growth Technologies
ST. JOHNS, FL / ACCESS Newswire / February 5, 2026 / Suggestion Box, Inc. (OTCID:SGTB) (the "Company") today announced that it has successfully completed all required filings and is designated as OTCID Basic. "This milestone reflects our commitment to transparency, regulatory compliance, and responsible corporate governance," said Dave Olund, Chief Executive Officer of Suggestion Box, Inc. "Becoming OTC Markets Current is a foundational step as we move into the next phase of the Company's growth."
TouchSource and CXAI Announce Strategic Partnership to Bring Agentic AI to Enterprise and Commercial Real Estate Experiences
CXAI's agentic AI platform will serve as the intelligence layer orchestrating experiences across TouchSource's in-venue infrastructure
Athena Bitcoin to Attend ATMIA US Conference 2026; Shane Miller to Represent the Company Onsite in Arlington, Texas
Athena will meet with industry stakeholders to explore affiliate partnerships, strategic partner opportunities, and deployment and expansion discussions
Innodata to Report Fourth Quarter and Fiscal Year 2025 Results
NEW YORK, NY / ACCESS Newswire / February 5, 2026 / INNODATA INC. (Nasdaq:INOD) today announced that it will report Fourth Quarter and Fiscal Year 2025 results after the market closes on Thursday, February 26, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com.
Rain Enhancement Technologies Expands Research into Air Quality and Smog Mitigation
New Research Initiative to Test if Ionization Can Remove Harmful Particles From the Atmosphere Before People Breathe Them
Whack-a-mole: US academic fights to purge his AI deepfakes
As deepfake videos of John Mearsheimer multiplied across YouTube, the American academic rushed to have them taken down, embarking on a grueling fight that laid bare the challenges of combating AI-driven impersonation.
Seven Oshyn Experts Honored with 2026 Sitecore Most Valuable Professional Awards
Seven specialists recognized for their technical mastery and strategic leadership within the global Sitecore ecosystem.
iBLOXX Secures USD 5.4 Million for Global Launch of StrayShot
iBLOXX Studios DMCC has raised USD 5.4 million to finalize development and support the global launch of its mobile-first third-person shooter, StrayShot. Based in Dubai and part of the DMCC Gaming Centre and Dubai Program for Gaming 2033, the studio collaborates with partners like the Dubai Future Foundation and Xsolla. StrayShot features multiple modes (Battle Royale, Team Deathmatch, Extraction), is optimized for low-end devices, and is set in the fictional region of Sierra Verde. Currently in closed testing, the game will include blockchain-enabled asset ownership. The funding will fuel global marketing, live operations, ongoing updates, and future console versions.
Ayrmid Reports Additional New Real-World Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease and Beta-Thalassemia
Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease and beta-thalassemia enabling accelerated access to gene therapies73% (11 of 15) of patients were able to collect sufficient HSC to enable progress to gene therapy manufacturing with 5 patients receiving their gene therapy and appropriately engrafted73% (11 of 15) of patients had previously failed to collect sufficient cells with plerixaforResults support the use of motixafortide as an effective single-agent mobilizer of HSC for people with sickle cell disease and in combination with G-CSF for beta-thalassemiaFindings presented at TANDEM 2026
Nextech3D.ai Expands Krafty Lab Enterprise Engagement Platform with F-35 Flight Simulation Experiences Through The Squadron Partnership
Partnership with The Squadron Introduces High-Fidelity Flight Simulation for Enterprise Leadership Development, Executive Offsites and Premium Engagement Programs
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant)
Bebuzee ($BBUZ) Sets the Stage for Global Push with Strategic Series of Super App Updates
MIAMI, FL / ACCESS Newswire / February 4, 2026 / Bebuzee Inc. ($BBUZ), the rapidly evolving next-generation super app company, today announced a strategic sequence of major platform updates scheduled over the next three consecutive release windows - this weekend, next weekend, and again in two weeks - designed to prime the platform for an expanded global push.
GameSquare Appoints Amaree Tanawong as Chief Operating Officer
Tanawong brings nearly two decades of experience scaling strategy, monetization, and operational platforms across YouTube, Meow Wolf, Fullscreen, and Yahoo
Water Tower Research Fireside Chat with Ainos: AI Nose Powering SmellTech Expansion and Scalable Value Creation
AI Nose advances through a dual-engine architecture, enabling scalable deploymentsIndustrial and semiconductor deployments broaden Ainos' commercial footprintRobotics momentum accelerates data flywheel growth and commercial scale-up in 2026
CAVU Resources, Inc. (OTC:CAVR) Provides Update on Timeline for Proposed Merger with Post Bid Ship, Inc.
TULSA, OKLAHOMA / ACCESS Newswire / February 4, 2026 / CAVU Resources, Inc. ("CAVR" or the "Company"), OTC, today issued an update regarding the timeline for its proposed spin-out and merger with Post Bid Ship, Inc. and PBS Recon, Inc.
Datametrex Expands Business In Data Centres
TORONTO, ONTARIO / ACCESS Newswire / February 4, 2026 / Datametrex AI Limited (the "Company" or "Datametrex") (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce the continued expansion of its business into modern data centre operations & infrastructure solutions business. As part of this expansion, the Company is deploying Nutanix-based hyperconverged infrastructure (HCI) solutions, which unify servers, storage, and networking into a single, integrated platform designed to enhance operational stability, scalability, processing speed, and capacity efficiencies. Currently, the company has had good success deploying in South Korea with these solutions. These solutions have had stronger performance than traditional based VMware products. The company looks to rollout these specific solutions in North America.
Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA Trial
GelrinC, the only restorative product for knee cartilage repair, has CE Mark approval in Europe and is currently at the midpoint of a pivotal FDA Phase III trial in the U.S.Ori Gon brings substantial public company, medtech, and capital markets experience
Expert Intelligence Raises $4.7M Seed Round to Automate Expert Judgment in Regulated Labs
SANTA CLARA, CA / ACCESS Newswire / February 4, 2026 / Expert Intelligence™, a startup building AI systems that automate expert decision-making in regulated laboratory environments, today announced it has raised a $4.7M seed round led by Sierra Ventures with participation from TSVC and Acorn Pacific Ventures.
CORRECTION FROM SOURCE: Expert Intelligence Raises $5.8 Million Seed Round to Bring AI Decision Automation to Regulated Laboratories
Updated funding amount